• Issue

    Respirology: Volume 20, Issue 4

    i, 521-690
    May 2015

ISSUE INFORMATION

Free Access

Issue Information

  • Page: i
  • First Published: 16 April 2015

INVITED REVIEW SERIES

Lung Cancer Practice, Implementing Evidence From Around the World

Modern Statistical Methods in Respiratory Medicine

ORIGINAL ARTICLES

Critical Care

T cell subsets in human airways prior to and following endobronchial administration of endotoxin

  • Pages: 579-586
  • First Published: 25 February 2015

In this human experimental study using bronchial instillation of endotoxin (LPS) the kinetics of specific T-cell subsets were studied. Increased frequency of Tregs was observed, thus suggesting that these cells may aid in the resolution of acute lung inflammation.

COPD

Inflammatory markers and mortality among US adults with obstructive lung function

  • Pages: 587-593
  • First Published: 04 March 2015

Among adults with OLF in the United States, the associations among C-reactive protein, fibrinogen and leukocyte count and mortality were examined. The hazard ratios for having 1, 2 or 3 elevated markers were 1.17 (95% CI: 0.71–1.94), 1.44 (95% CI: 0.89–2.32) and 2.08 (95% CI: 1.29–3.37), respectively.

Free Access

Relative contributions of emphysema and airway remodelling to airflow limitation in COPD: Consistent results from two cohorts

  • Pages: 594-601
  • First Published: 18 March 2015
graphic

We aimed to evaluate the relative contributions of emphysema and airway wall thickness measured by quantitative CT to airflow limitation in COPD. We found that CT-based emphysema predicted airflow limitation better than airway wall thickness. Thus, emphysema may make a greater contribution to airflow limitation than airway remodelling in COPD.

See Editorial, page 522

See Editor's Choice, page 689

The prevalence and patient characteristics of chronic obstructive pulmonary disease in non-smokers in Vietnam and Indonesia: An observational survey

  • Pages: 602-611
  • First Published: 17 March 2015

We conducted a population-based cross-sectional survey of the prevalence and patient characteristics of COPD in 1506 non-smokers from urban and rural Vietnam and Indonesia. The overall prevalence of COPD was 6.9% (95% CI: 5.7–8.3). Very few participants (6%) had been previously diagnosed with COPD.

Open Access

Irisin, a newly discovered myokine, is a novel biomarker associated with physical activity in patients with chronic obstructive pulmonary disease

  • Pages: 612-617
  • First Published: 20 March 2015

Serum levels of irisin increased in COPD patients following an 8-week training programme. Serum irisin level could be used as a novel biomarker associated with physical activity in patients with COPD and may prove to be a valuable tool in clinical follow up of COPD.

Free Access

Chronic bronchitis leads to accelerated hyperinflation in COPD patients during exercise

  • Pages: 618-625
  • First Published: 19 March 2015

This study compares exercise capacities by measuring in COPD patients with and without bronchitis, and investigates possible mechanisms responsible for the different responses during exercise. COPD patients with CB have a significantly lower exercise capacity mainly due to their accelerated dynamic hyperinflation during exercise.

New scoring system for the differentiation of chronic obstructive pulmonary disease and asthma

  • Pages: 626-632
  • First Published: 30 March 2015

Despite efforts to differentiate between COPD and asthma, misdiagnosis is still a serious problem in general practice, especially in a primary care setting. This study suggests a new scoring system that may be a useful tool for differentiating between COPD and asthma in primary care.

Interstitial Lung Disease

Free Access

Novel algorithm to identify and differentiate specific digital signature of breath sound in patients with diffuse parenchymal lung disease

  • Pages: 633-639
  • First Published: 15 April 2015
graphic

We developed an instrument and technology to capture lung sounds and filter off the admixed heart sounds. We utilized lung sounds from 8 controls and 20 patients with diffuse parenchymal lung disease to identify the accurate digital signature of normal and interstitial lung sounds and transform them into characteristic visual images.

See Editorial, page 524

See Editor's Choice, page 689

Physical activity in patients with idiopathic pulmonary fibrosis

  • Pages: 640-646
  • First Published: 27 February 2015

We evaluated physical activity in patients with IPF. The modified MRC scale, 6MWT distance, extent of honeycomb and reticular abnormality on HRCT scans of the chest, and serum KL-6 levels were strongly correlated with physical activity. Physical activity may be an important indicator in multifaceted evaluation of patients with IPF.

Current Australasian practice for diagnosis and management of idiopathic pulmonary fibrosis: Where are we now?

  • Pages: 647-653
  • First Published: 22 March 2015

This is the first study looking at Australian and New Zealand management of IPF, comparing two physician surveys conducted 15 years apart. Significant variation in practice was identified in both cohorts. With increasing understanding of disease pathogenesis and emerging therapeutic options, a guideline-based, standardized approach is needed.

Pleural Disease

Clinical features and survival of lung cancer patients with pleural effusions

  • Pages: 654-659
  • First Published: 23 February 2015

About 40% of lung cancer patients develop pleural effusions, of which half are so small to preclude a thoracentesis and do not progress to become symptomatic. They do not require a therapeutic procedure. However, they confer a survival disadvantage compared with those patients without pleural effusions.

Respiratory Infections

Risk factors and antibiotic therapy in P. aeruginosa community-acquired pneumonia

  • Pages: 660-666
  • First Published: 16 March 2015

Risk factors recommended by current guidelines only detect one third of the patients admitted with CAP due to P. aeruginosa. Not administrating antibiotics active against P. aeruginosa in the first 48 h increases 30-day mortality.

EDITOR'S CHOICE

Free Access

The Editor recommends this issue's articles to the reader

  • Pages: 689-690
  • First Published: 16 April 2015

See page 594: Relative contributions of emphysema and airway remodelling to airflow limitation in COPD: Consistent results from two cohorts NV Tho, Y Ryujin, E Ogawa, LTH Trang, R Kanda, K Goto, M Yamaguchi, T Nagao, LTT Lan and Y Nakano

See page 633: Novel algorithm to identify and differentiate specific digital signature of breath sound in patients with diffuse parenchymal lung disease P Bhattacharya, A Mondal, R Dey, D Saha and G Saha